Human Anti HCV ELISA Kit Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: H175812EF664EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Human Anti HCV ELISA Kit in Global, including the following market information:

Global Human Anti HCV ELISA Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Human Anti HCV ELISA Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Serum Test Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Anti HCV ELISA Kit include Roche, Siemens, Abbott Laboratories, Danaher, Bio-Rad Laboratories, BioMerieux, Qiagen, Meridian Bioscience and Hologic and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Anti HCV ELISA Kit companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Anti HCV ELISA Kit Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Human Anti HCV ELISA Kit Market Segment Percentages, by Type, 2021 (%)

• Serum Test Kits
• Plasma Test Kits

Global Human Anti HCV ELISA Kit Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Human Anti HCV ELISA Kit Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

Global Human Anti HCV ELISA Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Human Anti HCV ELISA Kit Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Anti HCV ELISA Kit revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Human Anti HCV ELISA Kit revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Siemens
• Abbott Laboratories
• Danaher
• Bio-Rad Laboratories
• BioMerieux
• Qiagen
• Meridian Bioscience
• Hologic
• Creative Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Anti HCV ELISA Kit Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Human Anti HCV ELISA Kit Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN ANTI HCV ELISA KIT OVERALL MARKET SIZE

2.1 Global Human Anti HCV ELISA Kit Market Size: 2021 VS 2028
2.2 Global Human Anti HCV ELISA Kit Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Human Anti HCV ELISA Kit Players in Global Market
3.2 Top Global Human Anti HCV ELISA Kit Companies Ranked by Revenue
3.3 Global Human Anti HCV ELISA Kit Revenue by Companies
3.4 Top 3 and Top 5 Human Anti HCV ELISA Kit Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Anti HCV ELISA Kit Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Anti HCV ELISA Kit Players in Global Market
  3.6.1 List of Global Tier 1 Human Anti HCV ELISA Kit Companies
  3.6.2 List of Global Tier 2 and Tier 3 Human Anti HCV ELISA Kit Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Human Anti HCV ELISA Kit Market Size Markets, 2021 & 2028
  4.1.2 Serum Test Kits
  4.1.3 Plasma Test Kits
4.2 By Type - Global Human Anti HCV ELISA Kit Revenue & Forecasts
  4.2.1 By Type - Global Human Anti HCV ELISA Kit Revenue, 2017-2022
  4.2.2 By Type - Global Human Anti HCV ELISA Kit Revenue, 2023-2028
  4.2.3 By Type - Global Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Anti HCV ELISA Kit Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Diagnostic Centers
5.2 By Application - Global Human Anti HCV ELISA Kit Revenue & Forecasts
  5.2.1 By Application - Global Human Anti HCV ELISA Kit Revenue, 2017-2022
  5.2.2 By Application - Global Human Anti HCV ELISA Kit Revenue, 2023-2028
  5.2.3 By Application - Global Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Human Anti HCV ELISA Kit Market Size, 2021 & 2028
6.2 By Region - Global Human Anti HCV ELISA Kit Revenue & Forecasts
  6.2.1 By Region - Global Human Anti HCV ELISA Kit Revenue, 2017-2022
  6.2.2 By Region - Global Human Anti HCV ELISA Kit Revenue, 2023-2028
  6.2.3 By Region - Global Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Human Anti HCV ELISA Kit Revenue, 2017-2028
  6.3.2 US Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.3.3 Canada Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.3.4 Mexico Human Anti HCV ELISA Kit Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Human Anti HCV ELISA Kit Revenue, 2017-2028
  6.4.2 Germany Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.4.3 France Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.4.4 U.K. Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.4.5 Italy Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.4.6 Russia Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.4.7 Nordic Countries Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.4.8 Benelux Human Anti HCV ELISA Kit Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Human Anti HCV ELISA Kit Revenue, 2017-2028
  6.5.2 China Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.5.3 Japan Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.5.4 South Korea Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.5.5 Southeast Asia Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.5.6 India Human Anti HCV ELISA Kit Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Human Anti HCV ELISA Kit Revenue, 2017-2028
  6.6.2 Brazil Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.6.3 Argentina Human Anti HCV ELISA Kit Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Human Anti HCV ELISA Kit Revenue, 2017-2028
  6.7.2 Turkey Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.7.3 Israel Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.7.4 Saudi Arabia Human Anti HCV ELISA Kit Market Size, 2017-2028
  6.7.5 UAE Human Anti HCV ELISA Kit Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Human Anti HCV ELISA Kit Major Product Offerings
  7.1.4 Roche Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Siemens
  7.2.1 Siemens Corporate Summary
  7.2.2 Siemens Business Overview
  7.2.3 Siemens Human Anti HCV ELISA Kit Major Product Offerings
  7.2.4 Siemens Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.2.5 Siemens Key News
7.3 Abbott Laboratories
  7.3.1 Abbott Laboratories Corporate Summary
  7.3.2 Abbott Laboratories Business Overview
  7.3.3 Abbott Laboratories Human Anti HCV ELISA Kit Major Product Offerings
  7.3.4 Abbott Laboratories Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.3.5 Abbott Laboratories Key News
7.4 Danaher
  7.4.1 Danaher Corporate Summary
  7.4.2 Danaher Business Overview
  7.4.3 Danaher Human Anti HCV ELISA Kit Major Product Offerings
  7.4.4 Danaher Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.4.5 Danaher Key News
7.5 Bio-Rad Laboratories
  7.5.1 Bio-Rad Laboratories Corporate Summary
  7.5.2 Bio-Rad Laboratories Business Overview
  7.5.3 Bio-Rad Laboratories Human Anti HCV ELISA Kit Major Product Offerings
  7.5.4 Bio-Rad Laboratories Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.5.5 Bio-Rad Laboratories Key News
7.6 BioMerieux
  7.6.1 BioMerieux Corporate Summary
  7.6.2 BioMerieux Business Overview
  7.6.3 BioMerieux Human Anti HCV ELISA Kit Major Product Offerings
  7.6.4 BioMerieux Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.6.5 BioMerieux Key News
7.7 Qiagen
  7.7.1 Qiagen Corporate Summary
  7.7.2 Qiagen Business Overview
  7.7.3 Qiagen Human Anti HCV ELISA Kit Major Product Offerings
  7.7.4 Qiagen Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.7.5 Qiagen Key News
7.8 Meridian Bioscience
  7.8.1 Meridian Bioscience Corporate Summary
  7.8.2 Meridian Bioscience Business Overview
  7.8.3 Meridian Bioscience Human Anti HCV ELISA Kit Major Product Offerings
  7.8.4 Meridian Bioscience Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.8.5 Meridian Bioscience Key News
7.9 Hologic
  7.9.1 Hologic Corporate Summary
  7.9.2 Hologic Business Overview
  7.9.3 Hologic Human Anti HCV ELISA Kit Major Product Offerings
  7.9.4 Hologic Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.9.5 Hologic Key News
7.10 Creative Diagnostics
  7.10.1 Creative Diagnostics Corporate Summary
  7.10.2 Creative Diagnostics Business Overview
  7.10.3 Creative Diagnostics Human Anti HCV ELISA Kit Major Product Offerings
  7.10.4 Creative Diagnostics Human Anti HCV ELISA Kit Revenue in Global Market (2017-2022)
  7.10.5 Creative Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Human Anti HCV ELISA Kit Market Opportunities & Trends in Global Market
Table 2. Human Anti HCV ELISA Kit Market Drivers in Global Market
Table 3. Human Anti HCV ELISA Kit Market Restraints in Global Market
Table 4. Key Players of Human Anti HCV ELISA Kit in Global Market
Table 5. Top Human Anti HCV ELISA Kit Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Human Anti HCV ELISA Kit Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Human Anti HCV ELISA Kit Revenue Share by Companies, 2017-2022
Table 8. Global Companies Human Anti HCV ELISA Kit Product Type
Table 9. List of Global Tier 1 Human Anti HCV ELISA Kit Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Anti HCV ELISA Kit Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Human Anti HCV ELISA Kit Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Human Anti HCV ELISA Kit Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Human Anti HCV ELISA Kit Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Human Anti HCV ELISA Kit Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Human Anti HCV ELISA Kit Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Human Anti HCV ELISA Kit Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Human Anti HCV ELISA Kit Product Offerings
Table 32. Roche Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 33. Siemens Corporate Summary
Table 34. Siemens Human Anti HCV ELISA Kit Product Offerings
Table 35. Siemens Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Laboratories Corporate Summary
Table 37. Abbott Laboratories Human Anti HCV ELISA Kit Product Offerings
Table 38. Abbott Laboratories Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 39. Danaher Corporate Summary
Table 40. Danaher Human Anti HCV ELISA Kit Product Offerings
Table 41. Danaher Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Laboratories Corporate Summary
Table 43. Bio-Rad Laboratories Human Anti HCV ELISA Kit Product Offerings
Table 44. Bio-Rad Laboratories Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 45. BioMerieux Corporate Summary
Table 46. BioMerieux Human Anti HCV ELISA Kit Product Offerings
Table 47. BioMerieux Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 48. Qiagen Corporate Summary
Table 49. Qiagen Human Anti HCV ELISA Kit Product Offerings
Table 50. Qiagen Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 51. Meridian Bioscience Corporate Summary
Table 52. Meridian Bioscience Human Anti HCV ELISA Kit Product Offerings
Table 53. Meridian Bioscience Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 54. Hologic Corporate Summary
Table 55. Hologic Human Anti HCV ELISA Kit Product Offerings
Table 56. Hologic Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)
Table 57. Creative Diagnostics Corporate Summary
Table 58. Creative Diagnostics Human Anti HCV ELISA Kit Product Offerings
Table 59. Creative Diagnostics Human Anti HCV ELISA Kit Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Human Anti HCV ELISA Kit Segment by Type in 2021
Figure 2. Human Anti HCV ELISA Kit Segment by Application in 2021
Figure 3. Global Human Anti HCV ELISA Kit Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Anti HCV ELISA Kit Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Anti HCV ELISA Kit Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Anti HCV ELISA Kit Revenue in 2021
Figure 8. By Type - Global Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 9. By Application - Global Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 10. By Region - Global Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 11. By Country - North America Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 12. US Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 16. Germany Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 17. France Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 24. China Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 28. India Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 30. Brazil Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Human Anti HCV ELISA Kit Revenue Market Share, 2017-2028
Figure 33. Turkey Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Human Anti HCV ELISA Kit Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Siemens Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Laboratories Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Danaher Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad Laboratories Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioMerieux Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Qiagen Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Meridian Bioscience Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Hologic Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Creative Diagnostics Human Anti HCV ELISA Kit Revenue Year Over Year Growth (US$, Mn) & (2017-2022)